{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T06:42:56Z","timestamp":1671864176821},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"S1","license":[{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T00:00:00Z","timestamp":1665532800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pathologie"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1007\/s00292-022-01136-7","type":"journal-article","created":{"date-parts":[[2022,10,12]],"date-time":"2022-10-12T15:03:29Z","timestamp":1665587009000},"page":"31-35","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Eine Einzelzell-RNA-Sequenzierung identifiziert Metabolismus und CD52 als neue Angriffspunkte in Ibrutinib-persistenten Mantelzelllymphomzellen"],"prefix":"10.1007","volume":"43","author":[{"given":"Viktoria","family":"Fuhr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ehsan","family":"Vafadarnejad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Dietrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panagiota","family":"Arampatzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Riedel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antoine-Emmanuel","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas","family":"Rosenwald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hilka","family":"Rauert-Wunderlich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,10,12]]},"reference":[{"key":"1136_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.semcancer.2011.09.006","volume":"21","author":"JA Burger","year":"2011","unstructured":"Burger\u00a0JA, Ford\u00a0RJ (2011) The microenvironment in mantle cell lymphoma: cellular and molecular pathways and emerging targeted therapies. Semin Cancer Biol 21:308\u2013312","journal-title":"Semin Cancer Biol"},{"key":"1136_CR2","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler\u00a0A, Hoffman\u00a0P, Smibert\u00a0P et al (2018) Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat Biotechnol 36:411\u2013420","journal-title":"Nat Biotechnol"},{"key":"1136_CR3","doi-asserted-by":"publisher","first-page":"3413","DOI":"10.1182\/blood-2002-07-1952","volume":"101","author":"S Faderl","year":"2003","unstructured":"Faderl\u00a0S, Thomas\u00a0DA, O\u2019Brien\u00a0S et\u00a0al (2003) Experience with alemtuzumab plus rituximab in patients with relapsed and refractory lymphoid malignancies. Blood 101:3413\u20133415","journal-title":"Blood"},{"key":"1136_CR4","doi-asserted-by":"publisher","first-page":"2276","DOI":"10.3390\/ijms22052276","volume":"22","author":"V Fuhr","year":"2021","unstructured":"Fuhr\u00a0V, Vafadarnejad\u00a0E, Dietrich\u00a0O et al (2021) Time-resolved scRNA-seq tracks the adaptation of a\u00a0sensitive MCL cell line to ibrutinib treatment. Int J Mol Sci 22:2276","journal-title":"Int J Mol Sci"},{"key":"1136_CR5","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1111\/bjh.15108","volume":"181","author":"O Hershkovitz-Rokah","year":"2018","unstructured":"Hershkovitz-Rokah\u00a0O, Pulver\u00a0D, Lenz\u00a0G et al (2018) Ibrutinib resistance in mantle cell lymphoma: clinical, molecular and treatment aspects. Br J Haematol 181:306\u2013319","journal-title":"Br J Haematol"},{"key":"1136_CR6","doi-asserted-by":"publisher","first-page":"3554","DOI":"10.1182\/blood.V99.10.3554","volume":"99","author":"MJ Keating","year":"2002","unstructured":"Keating\u00a0MJ, Flinn\u00a0I, Jain\u00a0V et al (2002) Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a\u00a0large international study. Blood 99:3554\u20133561","journal-title":"Blood"},{"key":"1136_CR7","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1038\/s41591-018-0052-4","volume":"24","author":"JR Molina","year":"2018","unstructured":"Molina\u00a0JR, Sun\u00a0Y, Protopopova\u00a0M et\u00a0al (2018) An inhibitor of oxidative phosphorylation exploits cancer vulnerability. Nat Med 24:1036\u20131046","journal-title":"Nat Med"},{"key":"1136_CR8","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1182\/blood-2016-05-716480","volume":"128","author":"S Nestorowa","year":"2016","unstructured":"Nestorowa\u00a0S, Hamey\u00a0FK, Pijuan Sala\u00a0B et al (2016) A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation. Blood 128:e20\u2013e31","journal-title":"Blood"},{"key":"1136_CR9","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1111\/bjh.13973","volume":"173","author":"H Rauert-Wunderlich","year":"2016","unstructured":"Rauert-Wunderlich\u00a0H, Rudelius\u00a0M, Ott\u00a0G et al (2016) Targeting protein kinase C in mantle cell lymphoma. Br J Haematol 173:394\u2013403","journal-title":"Br J Haematol"},{"key":"1136_CR10","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1182\/blood-2015-11-681460","volume":"128","author":"NS Saba","year":"2016","unstructured":"Saba\u00a0NS, Liu\u00a0D, Herman\u00a0SE et al (2016) Pathogenic role of B\u2011cell receptor signaling and canonical NF-\u03baB activation in mantle cell lymphoma. Blood 128:82\u201392","journal-title":"Blood"},{"key":"1136_CR11","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.matbio.2014.03.001","volume":"37","author":"LA Shevde","year":"2014","unstructured":"Shevde\u00a0LA, Samant\u00a0RS (2014) Role of osteopontin in the pathophysiology of cancer. Matrix Biol 37:131\u2013141","journal-title":"Matrix Biol"},{"key":"1136_CR12","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1111\/bjh.17419","volume":"195","author":"E Silkenstedt","year":"2021","unstructured":"Silkenstedt\u00a0E, Linton\u00a0K, Dreyling\u00a0M (2021) Mantle cell lymphoma\u2014advances in molecular biology, prognostication and treatment approaches. Br J Haematol 195:162\u2013173","journal-title":"Br J Haematol"},{"key":"1136_CR13","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.3390\/ijms18122740","volume":"18","author":"P Storti","year":"2017","unstructured":"Storti\u00a0P, Marchica\u00a0V, Giuliani\u00a0N (2017) Role of galectins in multiple myeloma. Int J Mol Sci 18:2740","journal-title":"Int J Mol Sci"},{"key":"1136_CR14","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart\u00a0T, Butler\u00a0A, Hoffman\u00a0P et al (2019) Comprehensive integration of single-cell data. Cell 177:1888\u20131902.e21","journal-title":"Cell"},{"key":"1136_CR15","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1056\/NEJMoa1306220","volume":"369","author":"ML Wang","year":"2013","unstructured":"Wang\u00a0ML, Rule\u00a0S, Martin\u00a0P et al (2013) Targeting BTK with ibrutinib in relapsed or refractory mantle-cell lymphoma. N\u00a0Engl J Med 369:507\u2013516","journal-title":"N Engl J Med"},{"key":"1136_CR16","first-page":"1629","volume":"61","author":"N Welzel","year":"2001","unstructured":"Welzel\u00a0N, Le\u00a0T, Marculescu\u00a0R et al (2001) Templated nucleotide addition and immunoglobulin JH-gene utilization in t(11;14) junctions: implications for the mechanism of translocation and the origin of mantle cell lymphoma. Cancer Res 61:1629\u20131636","journal-title":"Cancer Res"},{"key":"1136_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/bjc.2015.193","volume":"113","author":"SC Wightman","year":"2015","unstructured":"Wightman\u00a0SC, Uppal\u00a0A, Pitroda\u00a0SP et\u00a0al (2015) Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome. Br J Cancer 113:327\u2013335","journal-title":"Br J Cancer"},{"key":"1136_CR18","doi-asserted-by":"publisher","first-page":"eaau1167","DOI":"10.1126\/scitranslmed.aau1167","volume":"11","author":"L Zhang","year":"2019","unstructured":"Zhang\u00a0L, Yao\u00a0Y, Zhang\u00a0S et\u00a0al (2019) Metabolic reprogramming toward oxidative phosphorylation identifies a\u00a0therapeutic target for mantle cell lymphoma. Sci Transl Med 11:eaau1167","journal-title":"Sci Transl Med"}],"container-title":["Die Pathologie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-022-01136-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00292-022-01136-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-022-01136-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,23]],"date-time":"2022-12-23T12:03:55Z","timestamp":1671797035000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00292-022-01136-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,12]]},"references-count":18,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1136"],"URL":"https:\/\/doi.org\/10.1007\/s00292-022-01136-7","relation":{},"ISSN":["2731-7188","2731-7196"],"issn-type":[{"value":"2731-7188","type":"print"},{"value":"2731-7196","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,12]]},"assertion":[{"value":"12 September 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 October 2022","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"V.\u00a0Fuhr, E.\u00a0Vafadarnejad, O.\u00a0Dietrich, P.\u00a0Arampatzi, A.\u00a0Riedel, A.-E.\u00a0Saliba, A.\u00a0Rosenwald und H.\u00a0Rauert-Wunderlich geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"The supplement containing this article is not sponsored by industry.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}